Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.

ABSTRACT:

SUBMITTER: Sullivan HC 

PROVIDER: S-EPMC5454337 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature